Loading...

Steven Edelman

Title(s)Recall Faculty, Medicine
SchoolHealth Sciences
Address9500 Gilman Drive #0912
La Jolla CA 92093
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    KINETICS OF IN VIVO GLUCOSE UPTAKE IN DIABETES
    NIH/NIDDK F32DK008271Apr 15, 1989
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Correction to: InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring-Study Design. Diabetes Ther. 2020 May 02. Battelino T, Bosnyak Z, Danne T, Mukherjee B, Edelman S, Pilorget V, Choudhary P, Renard E, Bergenstal R. PMID: 32361833.
      View in: PubMed   Mentions:
    2. InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring-Study Design. Diabetes Ther. 2020 Apr; 11(4):1017-1027. Battelino T, Bosnyak Z, Danne T, Mukherjee B, Edelman S, Pilorget V, Choudhary P, Renard E, Bergenstal R. PMID: 32100192.
      View in: PubMed   Mentions:
    3. Burden of Cardiovascular Disease in Adult Patients with Type 1 Diabetes in the US. Pharmacoecon Open. 2020 Jan 29. Edelman S, Zhou FL, Preblick R, Verma S, Paranjape S, Davies MJ, Joish VN. PMID: 31997126.
      View in: PubMed   Mentions:
    4. A Tribute to Robert Roy Henry-The Classic "Academic Triple Threat": Accomplished Researcher, Inspiring Teacher, and Compassionate Clinician. Diabetes Care. 2020 Mar; 43(3):522-525. Edelman S, Olefsky J, Mudaliar S, Ciaraldi T, Baron A. PMID: 31964787.
      View in: PubMed   Mentions:    Fields:    
    5. Differences between patients with type 1 diabetes with optimal and suboptimal glycaemic control: A real-world study of more than 30?000 patients in a US electronic health record database. Diabetes Obes Metab. 2020 Apr; 22(4):622-630. Pettus JH, Zhou FL, Shepherd L, Mercaldi K, Preblick R, Hunt PR, Paranjape S, Miller KM, Edelman SV. PMID: 31789439.
      View in: PubMed   Mentions:    Fields:    
    6. Transitioning to Fixed-Ratio Combination Therapy: Five Frequently Asked Questions Health Care Providers Should Anticipate From Their Patients. Clin Diabetes. 2019 Oct; 37(4):386-390. Blumer I, Novak LM, Edelman S, Cavaiola TS. PMID: 31660014.
      View in: PubMed   Mentions:
    7. Persistence with Basal-Bolus Insulin Therapy in Patients with Type 2 Diabetes Mellitus and Effect on Clinical and Economic Outcomes: A Retrospective Claims Database Study. J Manag Care Spec Pharm. 2019 Dec; 25(12):1420-1431. Edelman SV, Ermakova A, Xiong Y, Sieradzan R, Taylor SD. PMID: 31550190.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Incidences of Severe Hypoglycemia and Diabetic Ketoacidosis and Prevalence of Microvascular Complications Stratified by Age and Glycemic Control in U.S. Adult Patients With Type 1 Diabetes: A Real-World Study. Diabetes Care. 2019 12; 42(12):2220-2227. Pettus JH, Zhou FL, Shepherd L, Preblick R, Hunt PR, Paranjape S, Miller KM, Edelman SV. PMID: 31548241.
      View in: PubMed   Mentions: 1     Fields:    
    9. Efficacy and safety of a morning injection of insulin glargine 300?units/mL versus insulin glargine 100?units/mL in adult patients with type 1 diabetes: A multicentre, randomized controlled trial using continuous glucose monitoring. Diabetes Obes Metab. 2019 08; 21(8):1906-1913. Pettus J, Gill J, Paranjape S, Stewart J, Malla S, Edelman S, Bergenstal RM, Bode B. PMID: 30993855.
      View in: PubMed   Mentions:    Fields:    
    10. Sodium-glucose co-transporter inhibitors as adjunctive treatment to insulin in type 1 diabetes: A review of randomized controlled trials. Diabetes Obes Metab. 2019 Apr; 21 Suppl 2:62-77. Boeder S, Edelman SV. PMID: 31081593.
      View in: PubMed   Mentions: 1     Fields:    
    11. Physician-patient communication at prescription of an additional oral drug for type 2 diabetes and its links to patient outcomes - New findings from the global IntroDia® study. Diabetes Res Clin Pract. 2019 Mar; 149:89-97. Edelman S, Belton A, Down S, Alzaid A, Capehorn M, Gamerman V, Nagel F, Lee J, Emmerson J, Polonsky WH. PMID: 30685350.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. A Randomized Controlled, Treat-to-Target Study Evaluating the Efficacy and Safety of Insulin Glargine 300 U/mL (Gla-300) Administered Using Either Device-Supported or Routine Titration in People With Type 2 Diabetes. J Diabetes Sci Technol. 2019 09; 13(5):881-889. Davies M, Bain S, Charpentier G, Flacke F, Goyeau H, Woloschak M, Hasslacher C, Vespasiani G, Edelman S. PMID: 30646755.
      View in: PubMed   Mentions:    Fields:    
    13. Physician experiences when discussing the need for additional oral medication with type 2 diabetes patients: Insights from the cross-national IntroDia® study. Diabetes Res Clin Pract. 2019 Feb; 148:179-188. Down S, Alzaid A, Polonsky WH, Belton A, Edelman S, Gamerman V, Nagel F, Lee J, Emmerson J, Capehorn M. PMID: 30641173.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. Reference Guide for Integrating Continuous Glucose Monitoring Into Clinical Practice. Diabetes Educ. 2019 02; 45(1_suppl):3S-20S. Kruger DF, Edelman SV, Hinnen DA, Parkin CG. PMID: 30541402.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Clinical Implications of Real-time and Intermittently Scanned Continuous Glucose Monitoring. Diabetes Care. 2018 11; 41(11):2265-2274. Edelman SV, Argento NB, Pettus J, Hirsch IB. PMID: 30348844.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    16. Recommendations for Initiating Use of Afrezza Inhaled Insulin in Individuals with Type 1 Diabetes. Diabetes Technol Ther. 2018 06; 20(6):448-451. Pettus J, Santos Cavaiola T, Edelman SV. PMID: 29901406.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    17. A GUIDE TO FOLLOW-ON BIOLOGICS AND BIOSIMILARS WITH A FOCUS ON INSULIN. Endocr Pract. 2018 Feb; 24(2):195-204. Dolinar R, Lavernia F, Edelman S. PMID: 29466056.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    18. Response to Comment on Edelman and Polonsky. Type 2 Diabetes in the Real World: The Elusive Nature of Glycemic Control. Diabetes Care 2017;40:1425-1432. Diabetes Care. 2018 02; 41(2):e18. Edelman SV, Polonsky WH. PMID: 29358472.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. Taking Control Of Your Diabetes: An Innovative Approach to Improving Diabetes Care Through Educating, Motivating, and Making the Connection Between Patients and Health Care Providers. Clin Diabetes. 2017 Dec; 35(5):333-339. Edelman SV. PMID: 29263578.
      View in: PubMed   Mentions:
    20. Addressing Unmet Needs With Injectable Medications in Type 2 Diabetes Treatment: Glucagon-Like Peptide-1 Receptor Agonists. J Fam Pract. 2017 Oct; 66(10 Suppl):S12-S16. Edelman SV. PMID: 28991932.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. Insights into optimal basal insulin titration in type 2 diabetes: Results of a quantitative survey. Diabetes Obes Metab. 2018 02; 20(2):301-308. Berard L, Bonnemaire M, Mical M, Edelman S. PMID: 28719066.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    22. Type 2 Diabetes in the Real World: The Elusive Nature of Glycemic Control. Diabetes Care. 2017 11; 40(11):1425-1432. Edelman SV, Polonsky WH. PMID: 28801473.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    23. Understanding the Gap Between Efficacy in Randomized Controlled Trials and Effectiveness in Real-World Use of GLP-1 RA and DPP-4 Therapies in Patients With Type 2 Diabetes. Diabetes Care. 2017 11; 40(11):1469-1478. Carls GS, Tuttle E, Tan RD, Huynh J, Yee J, Edelman SV, Polonsky WH. PMID: 28801475.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    24. Achievement of Glycated Hemoglobin Goals in the US Remains Unchanged Through 2014. Diabetes Ther. 2017 Aug; 8(4):863-873. Carls G, Huynh J, Tuttle E, Yee J, Edelman SV. PMID: 28646411.
      View in: PubMed   Mentions:
    25. Development and Content Validity of the Statin Experience Assessment Questionnaire (SEAQ)©. Patient. 2017 06; 10(3):321-334. Jacobson TA, Edelman SV, Galipeau N, Shields AL, Mallya UG, Koren A, Davidson MH. PMID: 27981439.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    26. Where Are We Now? A Clinicians' Guide to the Use of Follow-On Insulin for Patients with Diabetes. Am J Med. 2017 05; 130(5):614. Edelman SV, Hollander PA, Wright EE. PMID: 28431671.
      View in: PubMed   Mentions:    Fields:    
    27. Physician-patient communication at diagnosis of type 2 diabetes and its links to patient outcomes: New results from the global IntroDia® study. Diabetes Res Clin Pract. 2017 May; 127:265-274. Polonsky WH, Capehorn M, Belton A, Down S, Alzaid A, Gamerman V, Nagel F, Lee J, Edelman S. PMID: 28407552.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    28. Estimated Cost-Effectiveness, Cost Benefit, and Risk Reduction Associated with an Endocrinologist-Pharmacist Diabetes Intense Medical Management "Tune-Up" Clinic. J Manag Care Spec Pharm. 2017 Mar; 23(3):318-326. Hirsch JD, Bounthavong M, Arjmand A, Ha DR, Cadiz CL, Zimmerman A, Ourth H, Morreale AP, Edelman SV, Morello CM. PMID: 28230459.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    29. Administration of Biosimilar Insulin Analogs: Role of Devices. Diabetes Technol Ther. 2017 02; 19(2):79-84. Heinemann L, Fritz I, Khatami H, Edelman SV. PMID: 28118050.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    30. Investigating Hypoglycemic Confidence in Type 1 and Type 2 Diabetes. Diabetes Technol Ther. 2017 02; 19(2):131-136. Polonsky WH, Fisher L, Hessler D, Edelman SV. PMID: 27997217.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    31. Regulation Catches Up to Reality. J Diabetes Sci Technol. 2017 01; 11(1):160-164. Edelman SV. PMID: 27630249.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansPHPublic Health
    32. Differences in Use of Glucose Rate of Change (ROC) Arrows to Adjust Insulin Therapy Among Individuals With Type 1 and Type 2 Diabetes Who Use Continuous Glucose Monitoring (CGM). J Diabetes Sci Technol. 2016 09; 10(5):1087-93. Pettus J, Edelman SV. PMID: 27044518.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    33. Recommendations for Using Real-Time Continuous Glucose Monitoring (rtCGM) Data for Insulin Adjustments in Type 1 Diabetes. J Diabetes Sci Technol. 2017 01; 11(1):138-147. Pettus J, Edelman SV. PMID: 27530720.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    34. Making Insulin Accessible: Does Inhaled Insulin Fill an Unmet Need? Adv Ther. 2016 08; 33(8):1267-78. McGill JB, Ahn D, Edelman SV, Kilpatrick CR, Santos Cavaiola T. PMID: 27384191.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    35. Improvement of Insulin Injection Technique: Examination of Current Issues and Recommendations. Diabetes Educ. 2016 08; 42(4):379-94. Spollett G, Edelman SV, Mehner P, Walter C, Penfornis A. PMID: 27216036.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    36. Unblinded CGM Should Replace Blinded CGM in the Clinical Management of Diabetes. J Diabetes Sci Technol. 2016 05; 10(3):793-8. Ahn D, Pettus J, Edelman S. PMID: 26884422.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    37. Use of Glucose Rate of Change Arrows to Adjust Insulin Therapy Among Individuals with Type 1 Diabetes Who Use Continuous Glucose Monitoring. Diabetes Technol Ther. 2016 Feb; 18 Suppl 2:S234-42. Pettus J, Edelman SV. PMID: 26784128.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    38. The past, present, and future of basal insulins. Diabetes Metab Res Rev. 2016 09; 32(6):478-96. Pettus J, Santos Cavaiola T, Tamborlane WV, Edelman S. PMID: 26509843.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    39. Clinical Outcomes Associated With a Collaborative Pharmacist-Endocrinologist Diabetes Intense Medical Management "Tune Up" Clinic in Complex Patients. Ann Pharmacother. 2016 Jan; 50(1):8-16. Morello CM, Christopher ML, Ortega L, Khoan J, Rotunno T, Edelman SV, Henry RR, Hirsch JD. PMID: 26546580.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    40. BIOSIMILARS AND NEW INSULIN VERSIONS. Endocr Pract. 2015 Dec; 21(12):1387-94. Peters AL, Pollom RD, Zielonka JS, Carey MA, Edelman SV. PMID: 26340139.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    41. Development of a New Measure for Assessing Insulin Delivery Device Satisfaction in Patients with Type 1 and Type 2 Diabetes. Diabetes Technol Ther. 2015 Nov; 17(11):773-9. Polonsky WH, Fisher L, Hessler D, Edelman SV. PMID: 26167948.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    42. Development of a New Measure for Assessing Glucose Monitoring Device-Related Treatment Satisfaction and Quality of Life. Diabetes Technol Ther. 2015 Sep; 17(9):657-63. Polonsky WH, Fisher L, Hessler D, Edelman SV. PMID: 25923812.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    43. HOW PATIENTS WITH TYPE 1 DIABETES TRANSLATE CONTINUOUS GLUCOSE MONITORING DATA INTO DIABETES MANAGEMENT DECISIONS. Endocr Pract. 2015 Jun; 21(6):613-20. Pettus J, Price DA, Edelman SV. PMID: 25716635.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    44. Response to comment on Edelman et al. AUTONOMY: the first randomized trial comparing two patient-driven approaches to initiate and titrate prandial insulin lispro in type 2 diabetes. Diabetes Care 2014;37:2132-2140. Diabetes Care. 2014 Dec; 37(12):e263-4. Edelman SV, Liu R, Johnson J, Glass LC. PMID: 25414399.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    45. Comment on Little et al. Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2 × 2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring (HypoCOMPaSS). Diabetes Care 2014;37:2114-2122. Diabetes Care. 2014 Dec; 37(12):e270-1. Edelman SV. PMID: 25414404.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    46. Switching from multiple daily injections to CSII pump therapy: insulin expenditures in type 2 diabetes. Am J Manag Care. 2014 Nov 01; 20(11):e490-7. David G, Gill M, Gunnarsson C, Shafiroff J, Edelman S. PMID: 25730348.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    47. Challenges associated with insulin therapy in type 2 diabetes mellitus. Am J Med. 2014 Oct; 127(10 Suppl):S11-6. Edelman S, Pettus J. PMID: 25282008.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    48. Exploring the potential of the SGLT2 inhibitor dapagliflozin in type 1 diabetes: a randomized, double-blind, placebo-controlled pilot study. Diabetes Care. 2015 Mar; 38(3):412-9. Henry RR, Rosenstock J, Edelman S, Mudaliar S, Chalamandaris AG, Kasichayanula S, Bogle A, Iqbal N, List J, Griffen SC. PMID: 25271207.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    49. Higher proinflammatory cytokine production and spontaneous activation in some type 1 and type 2 diabetic subjects. Clin Immunol. 2014 Nov; 155(1):27-9. Sarikonda G, Sachithanantham S, Pettus J, Rodriguez-Calvo T, Phatak S, Edelman S, von Herrath M. PMID: 25173803.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    50. Biosimilar insulins are coming: what they are, what you need to know. Curr Med Res Opin. 2014 Nov; 30(11):2217-22. Edelman S, Polonsky WH, Parkin CG. PMID: 25105307.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    51. Inhaled insulin: a breath of fresh air? A review of inhaled insulin. Clin Ther. 2014 Aug 01; 36(8):1275-89. Santos Cavaiola T, Edelman S. PMID: 25044021.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    52. Testing versus guessing blood glucose values: impact on self-care behaviors in type 2 diabetes. Curr Med Res Opin. 2014 Sep; 30(9):1795-802. Pettus J, Stenger P, Schachner HC, Dunne N, Parkes JL, Pardo S, Edelman SV. PMID: 24889281.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    53. Biosimilar insulins are coming: the top 10 things you should know. Postgrad Med. 2014 May; 126(3):107-10. Blumer I, Edelman S. PMID: 24918796.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    54. AUTONOMY: the first randomized trial comparing two patient-driven approaches to initiate and titrate prandial insulin lispro in type 2 diabetes. Diabetes Care. 2014 Aug; 37(8):2132-40. Edelman SV, Liu R, Johnson J, Glass LC. PMID: 24742662.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    55. The Impact of Nocturnal Hypoglycemia on Clinical and Cost-Related Issues in Patients With Type 1 and Type 2 Diabetes. Diabetes Educ. 2014 05; 40(3):269-279. Edelman SV, Blose JS. PMID: 24695260.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    56. Impact of Biosimilar Insulins on Clinical Practice: Meeting Report. J Diabetes Sci Technol. 2014 Jan; 8(1):179-185. Dolinar RO, Edelman S, Heinemann L, Home P, Goyal S, Polonsky WH, Schellekens H. PMID: 24876554.
      View in: PubMed   Mentions: 4     Fields:    
    57. Comparative Assessment of Lixisenatide, Exenatide, and Liraglutide Pen Devices: A Pilot User-Based Study. J Diabetes Sci Technol. 2014 Jan; 8(1):123-131. Stauder U, Enginee D, Elton H, Penfornis A, Edelman S. PMID: 24876548.
      View in: PubMed   Mentions: 3     Fields:    
    58. CD8 T-cell reactivity to islet antigens is unique to type 1 while CD4 T-cell reactivity exists in both type 1 and type 2 diabetes. J Autoimmun. 2014 May; 50:77-82. Sarikonda G, Pettus J, Phatak S, Sachithanantham S, Miller JF, Wesley JD, Cadag E, Chae J, Ganesan L, Mallios R, Edelman S, Peters B, von Herrath M. PMID: 24387802.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    59. Temporal intra-individual variation of immunological biomarkers in type 1 diabetes patients: implications for future use in cross-sectional assessment. PLoS One. 2013; 8(11):e79383. Sarikonda G, Pettus J, Sachithanantham S, Phatak S, Miller JF, Ganesan L, Chae J, Mallios R, Edelman S, Peters B, von Herrath M. PMID: 24223938.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    60. Gastrointestinal complications of diabetes. Endocrinol Metab Clin North Am. 2013 Dec; 42(4):809-32. Boland BS, Edelman SV, Wolosin JD. PMID: 24286951.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    61. Pramlintide improved measures of glycemic control and body weight in patients with type 1 diabetes mellitus undergoing continuous subcutaneous insulin infusion therapy. Postgrad Med. 2013 May; 125(3):136-44. Herrmann K, Frias JP, Edelman SV, Lutz K, Shan K, Chen S, Maggs D, Kolterman OG. PMID: 23748514.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    62. GLP-1 agonists in type 1 diabetes. Clin Immunol. 2013 Dec; 149(3):317-23. Pettus J, Hirsch I, Edelman S. PMID: 23643354.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    63. Effect of early weight loss on type 2 diabetes mellitus after 2 years of gastric banding. Postgrad Med. 2012 Nov; 124(6):73-81. Edelman S, Bhoyrul S, Billy H, Cornell C, Okerson T. PMID: 23322140.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    64. Using multiple measures of glycemia to support individualized diabetes management: recommendations for clinicians, patients, and payers. Diabetes Technol Ther. 2012 Nov; 14(11):973-83; quiz 983. Hirsch IB, Amiel SA, Blumer IR, Bode BW, Edelman SV, Seley JJ, Verderese CA, Kilpatrick ES. PMID: 23066850.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    65. Insulin-pump therapy for type 1 diabetes mellitus. N Engl J Med. 2012 07 26; 367(4):383; author reply 383-4. Blumer I, Edelman SV, Hirsch IB. PMID: 22830479.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    66. A survey of blood glucose monitoring in patients with type 2 diabetes: are recommendations from health care professionals being followed? Curr Med Res Opin. 2011 Nov; 27 Suppl 3:31-7. Polonsky WH, Fisher L, Hessler D, Edelman SV. PMID: 22106976.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    67. A 16-week open-label, multicenter pilot study assessing insulin pump therapy in patients with type 2 diabetes suboptimally controlled with multiple daily injections. J Diabetes Sci Technol. 2011 Jul 01; 5(4):887-93. Frias JP, Bode BW, Bailey TS, Kipnes MS, Brunelle R, Edelman SV. PMID: 21880230.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    68. Ethnic differences in complementary and alternative medicine use among patients with diabetes. Complement Ther Med. 2010 Dec; 18(6):241-8. Villa-Caballero L, Morello CM, Chynoweth ME, Prieto-Rosinol A, Polonsky WH, Palinkas LA, Edelman SV. PMID: 21130360.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimals
    69. Saxagliptin: the evidence for its place in the treatment of type 2 diabetes mellitus. Core Evid. 2010 Oct 21; 5:23-37. Kulasa K, Edelman S. PMID: 21042540.
      View in: PubMed   Mentions:
    70. Are patients' initial experiences at the diagnosis of type 2 diabetes associated with attitudes and self-management over time? Diabetes Educ. 2010 Sep-Oct; 36(5):828-34. Polonsky WH, Fisher L, Guzman S, Sieber WJ, Philis-Tsimikas A, Edelman SV. PMID: 20729511.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    71. Insulin pump therapy in patients with type 2 diabetes safely improved glycemic control using a simple insulin dosing regimen. Diabetes Technol Ther. 2010 Aug; 12(8):627-33. Edelman SV, Bode BW, Bailey TS, Kipnes MS, Brunelle R, Chen X, Frias JP. PMID: 20615104.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    72. Insulin pen use for type 2 diabetes--a clinical perspective. Diabetes Technol Ther. 2010 Jun; 12 Suppl 1:S86-90. Bailey TS, Edelman SV. PMID: 20515313.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    73. Continuous glucose monitoring health outcomes. Diabetes Technol Ther. 2009 Jun; 11 Suppl 1:S68-74. Edelman SV, Bailey TS. PMID: 19469680.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    74. United States patient preference and usability for the new disposable insulin device Solostar versus other disposable pens. J Diabetes Sci Technol. 2008 Nov; 2(6):1157-60. Fischer JS, Edelman SV, Schwartz SL. PMID: 19885306.
      View in: PubMed   Mentions: 9     Fields:    
    75. Does addition of pramlintide to basal insulin improve glycemic control in type 2 diabetes mellitus? Nat Clin Pract Endocrinol Metab. 2008 Apr; 4(4):194-5. Edelman SV. PMID: 18283327.
      View in: PubMed   Mentions:    Fields:    
    76. Pramlintide in the treatment of diabetes mellitus. BioDrugs. 2008; 22(6):375-86. Edelman S, Maier H, Wilhelm K. PMID: 18998755.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    77. Optimizing diabetes treatment using an amylin analogue. Diabetes Educ. 2008 Jan-Feb; 34 Suppl 1:4S-10S. Edelman SV. PMID: 18268000.
      View in: PubMed   Mentions: 3     Fields:    
    78. The role of self-monitoring of blood glucose during the treatment of type 2 diabetes with medications targeting postprandial hyperglycemia. South Med J. 2007 Nov; 100(11):1123-31. Choe C, Edelman SV. PMID: 17984745.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    79. Incretins and their role in the management of diabetes. Curr Opin Endocrinol Diabetes Obes. 2007 Aug; 14(4):269-76. Frias JP, Edelman SV. PMID: 17940451.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    80. Is pramlintide a safe and effective adjunct therapy for patients with type 1 diabetes? Nat Clin Pract Endocrinol Metab. 2007 May; 3(5):E1; discussion E2. Edelman SV, Garg S, Kolterman OG. PMID: 17452962.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    81. A practical approach for implementation of a basal-prandial insulin therapy regimen in patients with type 2 diabetes. Osteopath Med Prim Care. 2007 Apr 20; 1:9. Edelman S, Dailey G, Flood T, Kuritzky L, Renda S. PMID: 17448241.
      View in: PubMed   Mentions:
    82. New therapeutic options for treating type-2 diabetes: a review of insulin analogs and premixed insulin analogs. J Natl Med Assoc. 2007 Apr; 99(4):357-60, 363-7. Choe C, Edelman S. PMID: 17444424.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    83. Comparison of usability and patient preference for the new disposable insulin device Solostar versus Flexpen, lilly disposable pen, and a prototype pen: an open-label study. Clin Ther. 2007 Apr; 29(4):650-60. Haak T, Edelman S, Walter C, Lecointre B, Spollett G. PMID: 17617288.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    84. Significant insulin dose errors may occur if blood glucose results are obtained from miscoded meters. J Diabetes Sci Technol. 2007 Mar; 1(2):205-10. Raine CH, Schrock LE, Edelman SV, Mudaliar SR, Zhong W, Proud LJ, Parkes JL. PMID: 19888408.
      View in: PubMed   Mentions: 16     Fields:    
    85. Through the looking glass: current and future perspectives on the role of hormonal interplay in glucose homeostasis. Diabetes Educ. 2007 02; 33 Suppl 2:32S-46S; quiz 47S-48S. Kruger DF, Aronoff SL, Edelman SV. PMID: 17483531.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    86. Pramlintide acetate in the treatment of Type 2 and Type 1 diabetes mellitus. Expert Rev Endocrinol Metab. 2007 Jan; 2(1):9-18. Edelman SV, Schroeder BE, Frias JP. PMID: 30743744.
      View in: PubMed   Mentions:    Fields:    
    87. A double-blind, placebo-controlled trial assessing pramlintide treatment in the setting of intensive insulin therapy in type 1 diabetes. Diabetes Care. 2006 Oct; 29(10):2189-95. Edelman S, Garg S, Frias J, Maggs D, Wang Y, Zhang B, Strobel S, Lutz K, Kolterman O. PMID: 17003291.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    88. Amylin replacement therapy in patients with type 1 diabetes. Diabetes Educ. 2006 May-Jun; 32 Suppl 3:119S-127S. Edelman SV, Caballero L. PMID: 16751353.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    89. Does a patient-administered titration algorithm of insulin glargine improve glycemic control? Nat Clin Pract Endocrinol Metab. 2006 Feb; 2(2):78-9. Edelman S. PMID: 16932261.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    90. Incretins: what does the future hold? Diabetes Technol Ther. 2005 Oct; 7(5):809-12. Edelman SV. PMID: 16241889.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    91. Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem. Diabetes Care. 2005 Oct; 28(10):2543-5. Polonsky WH, Fisher L, Guzman S, Villa-Caballero L, Edelman SV. PMID: 16186296.
      View in: PubMed   Mentions: 109     Fields:    Translation:Humans
    92. Strategies for insulin therapy in type 2 diabetes. South Med J. 2005 Mar; 98(3):363-71. Edelman SV, Morello CM. PMID: 15813164.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    93. Thiazolidinediones. N Engl J Med. 2005 Jan 13; 352(2):205-7; author reply 205-7. Edelman SV. PMID: 15651124.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    94. Hypoglycemia unawareness and type 1 diabetes. South Med J. 2004 Nov; 97(11):1143-4. Edelman SV, Morello CM. PMID: 15586620.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    95. Skeletal muscle GLUT1 transporter protein expression and basal leg glucose uptake are reduced in type 2 diabetes. J Clin Endocrinol Metab. 2005 Jan; 90(1):352-8. Ciaraldi TP, Mudaliar S, Barzin A, Macievic JA, Edelman SV, Park KS, Henry RR. PMID: 15483099.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    96. Prognostic role of B-type natriuretic peptide levels in patients with type 2 diabetes mellitus. J Am Coll Cardiol. 2004 Sep 01; 44(5):1047-52. Bhalla MA, Chiang A, Epshteyn VA, Kazanegra R, Bhalla V, Clopton P, Krishnaswamy P, Morrison LK, Chiu A, Gardetto N, Mudaliar S, Edelman SV, Henry RR, Maisel AS. PMID: 15337217.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    97. Insulin therapy in type 2 diabetes. Med Clin North Am. 2004 Jul; 88(4):865-95, x. Davis T, Edelman SV. PMID: 15308383.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    98. Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetes. Diabetes Care. 2004 Mar; 27(3):734-8. Garg SK, Schwartz S, Edelman SV. PMID: 14988294.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    99. BNP levels to screen for left ventricular dysfunction. Curr Diab Rep. 2004 Feb; 4(1):39-40. Chu NV, Edelman SV. PMID: 14764278.
      View in: PubMed   Mentions:    Fields:    
    100. Utility of B-type natriuretic peptide (BNP) as a screen for left ventricular dysfunction in patients with diabetes. Diabetes Care. 2003 Jul; 26(7):2081-7. Epshteyn V, Morrison K, Krishnaswamy P, Kazanegra R, Clopton P, Mudaliar S, Edelman S, Henry R, Maisel A. PMID: 12832317.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    101. Osteoporosis and diabetes. Curr Diab Rep. 2003 Feb; 3(1):37-42. Chau DL, Edelman SV, Chandran M. PMID: 12643144.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    102. Gastrointestinal disturbances in diabetes. Curr Diab Rep. 2003 Feb; 3(1):43-8. Chandran M, Chu NV, Edelman SV. PMID: 12643145.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    103. Pramlintide as an adjunct to insulin therapy. Curr Diab Rep. 2003 Feb; 3(1):35-6. Chu NV, Edelman SV. PMID: 12685439.
      View in: PubMed   Mentions: 1     Fields:    
    104. Serum 1,5-anhydroglucitol (GlycoMark ): a short-term glycemic marker. Diabetes Technol Ther. 2003; 5(3):355-63. Buse JB, Freeman JL, Edelman SV, Jovanovic L, McGill JB. PMID: 12828817.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansCellsPHPublic Health
    105. Aiming for, believing in, and achieving a target a1c of less than 7. J Am Pharm Assoc (Wash). 2003 Jan; 43(1):121-2. Edelman S. PMID: 23945818.
      View in: PubMed   Mentions:    Fields:    
    106. The role of the thiazolidinediones in the practical management of patients with type 2 diabetes and cardiovascular risk factors. Rev Cardiovasc Med. 2003; 4 Suppl 6:S29-37. Edelman SV. PMID: 14668701.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    107. Aiming for, believing in, and achieving a target A1c of less than 7. J Am Pharm Assoc (Wash). 2003 Jan-Feb; 43(1):121-2. Edelman S. PMID: 12585763.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    108. Pumps and type 2 diabetes. If you can improve your diabetes control, and if you can accommodate yourself to it, the pump might just be the best diabetes therapy for you. Diabetes Forecast. 2002 Jun; 55(6):62-5. Edelman SV. PMID: 14964172.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    109. Insulin pump therapy versus multiple daily injections. Curr Diab Rep. 2002 Feb; 2(1):47-8. Edelman SV. PMID: 15279019.
      View in: PubMed   Mentions:    Fields:    
    110. Erectile dysfunction and diabetes. Curr Diab Rep. 2002 Feb; 2(1):60-6. Chu NV, Edelman SV. PMID: 12643124.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    111. Unresolved challenges with insulin therapy in type 1 and type 2 diabetes: potential benefit of replacing amylin, a second beta-cell hormone. Diabetes Technol Ther. 2002; 4(2):175-89. Edelman SV, Weyer C. PMID: 12079621.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
    112. Pharmacokinetics and glucodynamics of rapid-, short-, and intermediate-acting insulins: comparison of jet injection to needle syringe. Diabetes Technol Ther. 2002; 4(6):863-6. Sarno MJ, Bell J, Edelman SV. PMID: 12614490.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    Steven's Networks
    Concepts (279)
    Derived automatically from this person's publications.
    _
    Co-Authors (17)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _